Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) had its target price reduced by equities research analysts at Canaccord Genuity Group from $10.00 to $9.50 in a research report issued on Wednesday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Canaccord Genuity Group's target price would indicate a potential upside of 38.89% from the company's current price.
Several other equities research analysts also recently issued reports on the stock. Oppenheimer cut their target price on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an "outperform" rating for the company in a research note on Monday, October 21st. Canaccord Genuity Group raised Bioceres Crop Solutions to a "strong-buy" rating in a report on Friday, July 19th. Roth Mkm cut their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a "buy" rating for the company in a research note on Wednesday, September 11th. Finally, Lake Street Capital lowered their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a "buy" rating for the company in a research report on Wednesday, September 11th. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average price target of $12.13.
Check Out Our Latest Research Report on BIOX
Bioceres Crop Solutions Trading Up 2.8 %
Shares of BIOX stock traded up $0.18 on Wednesday, reaching $6.84. 582,746 shares of the stock were exchanged, compared to its average volume of 88,753. The stock has a market cap of $429.89 million, a PE ratio of 360.68 and a beta of 0.49. Bioceres Crop Solutions has a one year low of $5.71 and a one year high of $14.05. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.86. The stock has a 50 day moving average price of $7.73 and a 200 day moving average price of $9.85.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings data on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). The firm had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same quarter in the prior year, the company earned ($0.07) EPS. Equities research analysts forecast that Bioceres Crop Solutions will post 0.31 EPS for the current fiscal year.
Institutional Investors Weigh In On Bioceres Crop Solutions
Several large investors have recently modified their holdings of BIOX. Oak Family Advisors LLC boosted its stake in Bioceres Crop Solutions by 1.9% in the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company's stock worth $728,000 after purchasing an additional 1,208 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock worth $688,000 after buying an additional 5,341 shares during the period. Oppenheimer & Co. Inc. bought a new stake in Bioceres Crop Solutions in the first quarter valued at approximately $139,000. Lazard Asset Management LLC purchased a new stake in Bioceres Crop Solutions during the 1st quarter valued at $212,000. Finally, Ping Capital Management Inc. purchased a new stake in shares of Bioceres Crop Solutions during the second quarter worth about $448,000. Hedge funds and other institutional investors own 17.68% of the company's stock.
Bioceres Crop Solutions Company Profile
(
Get Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
See Also
Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.